Erratum

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)

Authors

Hisashi Yamanaka¹, Yoshiya Tanaka², Naoya Sekiguchi³, Eisuke Inoue¹, Kazuyoshi Saito², Hideto Kameda³, Noriko Iikuni¹, Masao Nawata², Kouichi Amano³, Mikiko Shinozaki¹ and Tsutomu Takeuchi³

1. Institute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
2. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
3. Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University, Saitama, Japan

Received:

25 October 2006

Accepted:

26 December 2006

Without Abstract

Key words

EULAR response - Infliximab - Retrospective study - Rheumatoid arthritis

The online version of the original article can be found at

here